453 related articles for article (PubMed ID: 17499764)
1. Adiponectin protects against the development of systolic dysfunction following myocardial infarction.
Shibata R; Izumiya Y; Sato K; Papanicolaou K; Kihara S; Colucci WS; Sam F; Ouchi N; Walsh K
J Mol Cell Cardiol; 2007 Jun; 42(6):1065-74. PubMed ID: 17499764
[TBL] [Abstract][Full Text] [Related]
2. FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism.
Joki Y; Ohashi K; Yuasa D; Shibata R; Ito M; Matsuo K; Kambara T; Uemura Y; Hayakawa S; Hiramatsu-Ito M; Kanemura N; Ogawa H; Daida H; Murohara T; Ouchi N
Biochem Biophys Res Commun; 2015 Mar; 459(1):124-30. PubMed ID: 25712519
[TBL] [Abstract][Full Text] [Related]
3. Induced adipocyte cell-sheet ameliorates cardiac dysfunction in a mouse myocardial infarction model: a novel drug delivery system for heart failure.
Imanishi Y; Miyagawa S; Maeda N; Fukushima S; Kitagawa-Sakakida S; Daimon T; Hirata A; Shimizu T; Okano T; Shimomura I; Sawa Y
Circulation; 2011 Sep; 124(11 Suppl):S10-7. PubMed ID: 21911798
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
[TBL] [Abstract][Full Text] [Related]
5. Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction.
Xiao J; Moon M; Yan L; Nian M; Zhang Y; Liu C; Lu J; Guan H; Chen M; Jiang D; Jiang H; Liu PP; Li H
Basic Res Cardiol; 2012 Jan; 107(1):239. PubMed ID: 22202974
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction.
Krishnamurthy P; Peterson JT; Subramanian V; Singh M; Singh K
Mol Cell Biochem; 2009 Feb; 322(1-2):53-62. PubMed ID: 18979185
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
Janssens S; Pokreisz P; Schoonjans L; Pellens M; Vermeersch P; Tjwa M; Jans P; Scherrer-Crosbie M; Picard MH; Szelid Z; Gillijns H; Van de Werf F; Collen D; Bloch KD
Circ Res; 2004 May; 94(9):1256-62. PubMed ID: 15044322
[TBL] [Abstract][Full Text] [Related]
8. Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction.
Sam F; Sawyer DB; Xie Z; Chang DL; Ngoy S; Brenner DA; Siwik DA; Singh K; Apstein CS; Colucci WS
Circ Res; 2001 Aug; 89(4):351-6. PubMed ID: 11509452
[TBL] [Abstract][Full Text] [Related]
9. Intravenous miR-144 reduces left ventricular remodeling after myocardial infarction.
Li J; Cai SX; He Q; Zhang H; Friedberg D; Wang F; Redington AN
Basic Res Cardiol; 2018 Aug; 113(5):36. PubMed ID: 30084039
[TBL] [Abstract][Full Text] [Related]
10. Association of dietary iron restriction with left ventricular remodeling after myocardial infarction in mice.
Eguchi A; Naito Y; Iwasaku T; Okuhara Y; Morisawa D; Sawada H; Nishimura K; Oboshi M; Fujii K; Mano T; Masuyama T; Hirotani S
Heart Vessels; 2016 Feb; 31(2):222-9. PubMed ID: 25573257
[TBL] [Abstract][Full Text] [Related]
11. Gender-specific patterns of left ventricular and myocyte remodeling following myocardial infarction in mice deficient in the angiotensin II type 1a receptor.
Bridgman P; Aronovitz MA; Kakkar R; Oliverio MI; Coffman TM; Rand WM; Konstam MA; Mendelsohn ME; Patten RD
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H586-92. PubMed ID: 15764682
[TBL] [Abstract][Full Text] [Related]
12. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction.
Ding L; Dong L; Chen X; Zhang L; Xu X; Ferro A; Xu B
Circulation; 2009 Sep; 120(9):764-73. PubMed ID: 19687354
[TBL] [Abstract][Full Text] [Related]
14. Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density.
McQueen AP; Zhang D; Hu P; Swenson L; Yang Y; Zaha VG; Hoffman JL; Yun UJ; Chakrabarti G; Wang Z; Albertine KH; Abel ED; Litwin SE
J Mol Cell Cardiol; 2005 Dec; 39(6):882-92. PubMed ID: 16216265
[TBL] [Abstract][Full Text] [Related]
15. Ataxia telangiectasia-mutated kinase deficiency exacerbates left ventricular dysfunction and remodeling late after myocardial infarction.
Daniel LL; Scofield SL; Thrasher P; Dalal S; Daniels CR; Foster CR; Singh M; Singh K
Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H445-52. PubMed ID: 27288435
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective role of growth/differentiation factor 1 in post-infarction left ventricular remodelling and dysfunction.
Bao MW; Zhang XJ; Li L; Cai Z; Liu X; Wan N; Hu G; Wan F; Zhang R; Zhu X; Xia H; Li H
J Pathol; 2015 Jul; 236(3):360-72. PubMed ID: 25726944
[TBL] [Abstract][Full Text] [Related]
17. TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.
Tian H; Cimini M; Fedak PW; Altamentova S; Fazel S; Huang ML; Weisel RD; Li RK
J Mol Cell Cardiol; 2007 Dec; 43(6):733-43. PubMed ID: 17945252
[TBL] [Abstract][Full Text] [Related]
18. Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction.
Qian JY; Harding P; Liu Y; Shesely E; Yang XP; LaPointe MC
Hypertension; 2008 Feb; 51(2):560-6. PubMed ID: 18180401
[TBL] [Abstract][Full Text] [Related]
19. Neuron-derived neurotrophic factor ameliorates adverse cardiac remodeling after experimental myocardial infarction.
Joki Y; Ohashi K; Yuasa D; Shibata R; Kataoka Y; Kambara T; Uemura Y; Matsuo K; Hayakawa S; Hiramatsu-Ito M; Kanemura N; Ito M; Ogawa H; Daida H; Murohara T; Ouchi N
Circ Heart Fail; 2015 Mar; 8(2):342-51. PubMed ID: 25654972
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling.
Oishi Y; Ozono R; Yano Y; Teranishi Y; Akishita M; Horiuchi M; Oshima T; Kambe M
Hypertension; 2003 Mar; 41(3 Pt 2):814-8. PubMed ID: 12624001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
